Pharming Group N.V. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 29.52M40.56M37.75M-7.06M16.92M-3.12M-11.97M
Share-based Compensation 3.86M4.29M6.54M
Gains from Investment Securities 1.55M136.48M-0.00M146.51M
Change in Working Capital 5.69M-0.44M3.92M4.96M-1.58M16.96M10.07M
Change in Receivables -7.74M-7.80M-7.04M46.16M
Change in Inventory 1.20M4.24M-4.93M-6.15M-15.02M-14.43M-0.50M
Change in Account Payables 1.64M6.86M7.02M
Cash from Operations 47.85M74.15M83.63M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.83M
Depreciation & Amortization (CF) 7.75M5.80M8.31M
Investing Activities
Capital Expenditures 2.95M2.65M4.66M10.74M1.38M1.44M0.80M
Cash from Investing Activities -4.45M-28.26M-15.63M
Financing Activities
Cash from Financing Activities -21.22M-63.47M60.69M
Additional items
Exchange Rate Effect 3.40M0.06M2.13M
Change in Cash 22.18M-17.58M128.68M-11.41M22.80M-147.73M-4.59M
Beginning Cash Balance 72.69M91.93M76.48M11.61M-22.80M147.73M4.59M
Free Cash Flow 44.90M71.50M78.97M-10.74M-1.38M-1.44M-0.80M
Net Cash Flow 22.18M-17.58M128.68M